Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRT plus Procrit for Anemia-Related Fatigue in Cancer
NCT00004914Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jan 2000
- Primary completion
- Dec 2001
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of epoetin alfa in anemia, sponsored by Northwestern University. Primary endpoints: Lean Body Mass at 12 weeks, Fatigue at 12 weeks and 3 more. Started Jan 2000; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00004914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004914.